Uptake of Outpatient Monoclonal Antibody Treatments for COVID-19 in the United States: a Cross-Sectional Analysis

J Gen Intern Med. 2021 Dec;36(12):3922-3924. doi: 10.1007/s11606-021-07109-5. Epub 2021 Sep 8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal
  • COVID-19*
  • Cross-Sectional Studies
  • Humans
  • Outpatients
  • SARS-CoV-2
  • United States

Substances

  • Antibodies, Monoclonal